US Broker Ratings

MeiraGTx Holdings plc (MGTX) Stock Analysis: Uncovering a 134.5% Potential Upside

Investors with a keen eye on the biotechnology sector might find MeiraGTx Holdings plc (NASDAQ: MGTX) an intriguing prospect. This clinical-stage genetic medicines company based in New York is making..

Savara, Inc. (SVRA) Stock Analysis: Biotechnology Gem with Significant Upside Potential

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is making waves in the healthcare sector, particularly in the biotechnology industry, with its focus on rare respiratory diseases. Headquartered in Yardley,..

Maravai LifeSciences Holdings (MRVI) Stock Report: Navigating Growth in a Volatile Biotech Landscape

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a notable player in the biotechnology sector, offering a wide array of innovative products that support drug therapies, vaccines, and diagnostics across..

iRadimed Corporation (IRMD) Stock Report: Exploring a 25.72% Upside in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specifically in the medical devices industry, is gaining attention from investors due to its impressive market performance and promising..

Theravance Biopharma, Inc. (TBPH) Investor Outlook: Analyzing Its 50% ROE and Growth Potential in the Biotech Sector

Theravance Biopharma, Inc. (NASDAQ: TBPH), a notable player in the biotechnology sector, is drawing investor attention with its standout financial metrics, particularly its impressive 50.17% return on equity (ROE). Headquartered..

AxoGen, Inc. (AXGN) Stock Report: Exploring the 27.81% Potential Upside in Peripheral Nerve Regeneration

For investors keen on the healthcare sector, AxoGen, Inc. (NASDAQ: AXGN) presents an intriguing opportunity. Operating within the medical devices industry, AxoGen specializes in peripheral nerve regeneration and repair technologies—a..

Myriad Genetics, Inc. (MYGN): Investor Outlook Reveals 9.65% Potential Upside in the Healthcare Sector

Myriad Genetics, Inc. (NASDAQ: MYGN) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Based in the United States, this molecular diagnostics and..

Embecta Corp. (EMBC) Stock Analysis: Exploring a 23% Potential Upside with a Strong Dividend Yield

Embecta Corp. (EMBC), a stalwart in the healthcare sector specializing in medical instruments and supplies, has caught the attention of investors with its robust dividend yield and a notable potential..

Bioventus Inc. (BVS) Stock Analysis: Exploring a 28.92% Potential Upside in the Medical Device Sector

Bioventus Inc. (NASDAQ: BVS) has emerged as an intriguing option for investors looking to capitalize on growth within the healthcare sector, particularly in the medical devices industry. With a market..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: Strong Buy Ratings Amid Innovative Biotech Advancements

Investors with a keen eye on the biotechnology sector should take note of Spyre Therapeutics, Inc. (NASDAQ: SYRE), a promising player in the healthcare industry with a focus on innovative..

Sonida Senior Living, Inc. (SNDA) Stock Report: Navigating Growth in Senior Care with a 38.5% Revenue Surge

Sonida Senior Living, Inc. (SNDA) stands at the forefront of the senior housing industry in the United States, offering a comprehensive suite of services to aging adults, from independent and..

Bicycle Therapeutics plc (BCYC) Stock Report: Exploring a 226% Potential Upside in the Biotechnology Sector

Bicycle Therapeutics plc (BCYC), a clinical-stage biopharmaceutical company, is garnering attention from investors for its innovative approach to tackling diseases that current therapeutics struggle to address. Headquartered in Cambridge, United..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Biotech Play with Mixed Signals and Growth Potential

Fortrea Holdings Inc. (NASDAQ: FTRE) is navigating the intricate landscape of the biotechnology industry with a focus on providing comprehensive research solutions for biopharmaceutical and medical device development. Incorporated in..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Navigating a 52.40% Potential Upside in the Biotech Sector

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, has captured investor attention with its promising therapeutic innovations in the healthcare sector. Specializing in the..

Personalis, Inc. (PSNL) Investor Outlook: Analyzing Growth Potential Amidst a 13.54% Upside

Personalis, Inc. (NASDAQ: PSNL), a notable player in the healthcare sector specializing in cancer genomics, is making waves in the diagnostics and research industry. As investors turn their attention to..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Assessing Growth Potential Amid a Challenging Market Landscape

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a medical technology firm focused on innovative solutions for bunion deformity correction. Despite its niche specialization in the healthcare sector, the company is..

AnaptysBio, Inc. (ANAB) Investor Outlook: Exploring a 58.61% Potential Upside

AnaptysBio, Inc. (ANAB), a clinical-stage biotechnology firm rooted in San Diego, is making waves in the healthcare sector with its promising pipeline of immunology therapeutics. As the company focuses on..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Understanding the Unchanged Landscape in Biotech

KalVista Pharmaceuticals, Inc. (KALV), a key player in the biotechnology sector, operates from its headquarters in Framingham, Massachusetts. As a company dedicated to developing groundbreaking oral therapies for rare diseases,..

InMode Ltd. (INMD): Investor Outlook Highlights Strong Global Presence and Growth Potential

InMode Ltd. (NASDAQ: INMD), an innovative player in the healthcare sector, continues to capture investor attention with its robust portfolio of minimally invasive aesthetic medical products. Headquartered in Yokne’am, Israel,..

Tectonic Therapeutic, Inc. (TECX): Analyst Ratings Signal a Potential 148% Upside for Innovative Biotech Player

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has emerged as a fascinating player in the biotechnology sector, capturing investor attention with its cutting-edge approach to drug discovery and development. Specializing in therapeutic..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds